Clinical Practice

Use the tool below to view all available Global Oncology Academy Series

- Edward Chu, MD
  Peer
- Michael J. Overman, MD
  Peer
5
CME/CE
Keeping Pace in GI Cancer: Advances in Immunotherapy in MSI-H/dMMR Metastatic Colorectal Cancer
Keeping Pace in GI Cancer: Advances in Immunotherapy in MSI-H/dMMR Metastatic Colorectal Cancer
0.25 credits
Keeping Pace in GI Cancer: Advances in Immunotherapy in MSI-H/dMMR Metastatic...
0.25 credits
- Marianne J. Davies, DNP, ACNP, AOCNP
  Peer
- Julie R. Brahmer, MD, MSc
  Peer
4
CME/CE
Addressing Barriers in Managing IRAEs Associated with Immune Checkpoint Inhibitor Therapy
Addressing Barriers in Managing IRAEs Associated with Immune Checkpoint Inhibitor Therapy
0.25 credits
Addressing Barriers in Managing IRAEs Associated with Immune Checkpoint Inhib...
0.25 credits
- Robert Mocharnuk, MD
  Peer
- Hossein Borghaei, MS, DO
  Peer
7
CME/CE
Part II: Precision Medicine in NSCLC—Implications for Molecular Testing and Treatment
Part II: Precision Medicine in NSCLC—Implications for Molecular Testing and Treatment
0.50 credits
Part II: Precision Medicine in NSCLC—Implications for Molecular Testing and T...
0.50 credits
- Robert Mocharnuk, MD
  Peer
- Hossein Borghaei, MS, DO
  Peer
4
CME/CE
Part I: Precision Medicine in NSCLC—Implications for Molecular Testing and Treatment
Part I: Precision Medicine in NSCLC—Implications for Molecular Testing and Treatment
0.50 credits
Part I: Precision Medicine in NSCLC—Implications for Molecular Testing and Tr...
0.50 credits
- Gilberto de Lima Lopes Junior, MD, MBA, FAMS
  Peer
- Kai He, MD, PhD
  Peer
- Jyoti D. Patel, MD, FASCO
  Peer
4
CME/CE
Keeping Pace with Immunotherapy Advances in Non-Small Cell Lung Cancer: Global Lessons
Keeping Pace with Immunotherapy Advances in Non-Small Cell Lung Cancer: Global Lessons
0.25 credits
Keeping Pace with Immunotherapy Advances in Non-Small Cell Lung Cancer: Globa...
0.25 credits
- Mark A. Socinski, MD
  Peer
- Gilberto de Lima Lopes Junior, MD, MBA, FAMS
  Peer
5
CME/CE
Keeping Pace: The Use of Immunotherapy in Mutation-Positive Non-Small Cell Lung Cancer
Keeping Pace: The Use of Immunotherapy in Mutation-Positive Non-Small Cell Lung Cancer
0.25 credits
Keeping Pace: The Use of Immunotherapy in Mutation-Positive Non-Small Cell Lu...
0.25 credits
- William D. Tap, MD
  Peer
- John Healey, MD
  Peer
8
CME/CE
Best Practices in the Treatment of Tenosynovial Giant Cell Tumor (TGCT)
Best Practices in the Treatment of Tenosynovial Giant Cell Tumor (TGCT)
0.25 credits
Best Practices in the Treatment of Tenosynovial Giant Cell Tumor (TGCT)
0.25 credits
- Mark A. Socinski, MD
  Peer
- Edward B. Garon, MD, MS
  Peer
4
CME/CE
Keeping Pace: The Role of Immunotherapy After Disease Progression
Keeping Pace: The Role of Immunotherapy After Disease Progression
0.25 credits
Keeping Pace: The Role of Immunotherapy After Disease Progression
0.25 credits
- Sara Tolaney MD, MPH
  Peer
2
Breaking Boundaries in Breast Cancer
Emerging Roles for Immunotherapy in HER2+ Breast Cancer
Emerging Roles for Immunotherapy in HER2+ Breast Cancer
Emerging Roles for Immunotherapy in HER2+ Breast Cancer
- Sara Tolaney MD, MPH
  Peer
2
Breaking Boundaries in Breast Cancer
New Treatment Strategies for HER2+ Breast Cancer: The Latest from ASCO
New Treatment Strategies for HER2+ Breast Cancer: The Latest from ASCO
New Treatment Strategies for HER2+ Breast Cancer: The Latest from ASCO
- Bora Lim, M.D.
  Peer
0
Breaking Boundaries in Breast Cancer
What the PADA-1 Study Means for the Future of Breast Cancer Treatment
What the PADA-1 Study Means for the Future of Breast Cancer Treatment
What the PADA-1 Study Means for the Future of Breast Cancer Treatment
- Fred R. Hirsch, MD, PhD
  Peer
0
Closing the Gaps in NSCLC
The Role of Oncogene Addiction in RET Mutations & Treatment Selection
The Role of Oncogene Addiction in RET Mutations & Treatment Selection
The Role of Oncogene Addiction in RET Mutations & Treatment Selection
- Warner K. Huh, MD
  Peer
- Deborah K. Armstrong, MD
  Peer
- Robert L. Coleman, MD, FACOG, FACS
  Peer
13
CME/CE
Keeping Pace in Women's Cancer: The Role of PARP Inhibitors in Ovarian Cancer
Keeping Pace in Women's Cancer: The Role of PARP Inhibitors in Ovarian Cancer
0.25 credits
Keeping Pace in Women's Cancer: The Role of PARP Inhibitors in Ovarian Cancer
0.25 credits
- Javier Cortes, MD, PhD
  Peer
- Giuseppe Curigliano, MD, PhD
  Peer
- Peter Schmid, FRCP, MD, PhD
  Peer
3
CME/CE
Applying Real-World Evidence to Improve Clinical Decision-Making for Patients with HR-positive/HER2-negative Metastatic Breast Cancer
Applying Real-World Evidence to Improve Clinical Decision-Making for Patients with HR-positive/HER2-negative Metastatic Breast Cancer
0.25 credits
Applying Real-World Evidence to Improve Clinical Decision-Making for Patients...
0.25 credits
- Jennifer Caudle, DO
  Peer
- Ari Brooks, MD
  Peer
3
Medical Breakthroughs from Penn Medicine
Catching Up on Current & Future Breast Cancer Clinical Trials
Catching Up on Current & Future Breast Cancer Clinical Trials
Catching Up on Current & Future Breast Cancer Clinical Trials
- Jonathan Riess, MD, MS
  Peer
0
Closing the Gaps in NSCLC
Helping NSCLC Patients Cope with the Unexpected
Helping NSCLC Patients Cope with the Unexpected
Helping NSCLC Patients Cope with the Unexpected

Popular

CME/CE

CME/CE

CME/CE

CME/CE

CME/CE

CME/CE

CME/CE

CME/CE

Breaking Boundaries in Breast Cancer

Breaking Boundaries in Breast Cancer

Breaking Boundaries in Breast Cancer

Closing the Gaps in NSCLC

CME/CE

CME/CE

Medical Breakthroughs from Penn Medicine

Closing the Gaps in NSCLC

NEED HELP?

Contact us

NEED HELP?

Contact us

Popular

CME/CE

CME/CE

CME/CE

CME/CE

CME/CE

CME/CE

CME/CE

CME/CE

Breaking Boundaries in Breast Cancer

Breaking Boundaries in Breast Cancer

Breaking Boundaries in Breast Cancer

Closing the Gaps in NSCLC

CME/CE

CME/CE

Medical Breakthroughs from Penn Medicine

Closing the Gaps in NSCLC

Title

Share on ReachMD

Get a Dose of Global Oncology Academy in Your Inbox and Practice Smarter Medicine

Welcome to the newGlobal Oncology Academy website.

Welcome to the new
Global Oncology Academy website.